US FDA Classifies Lupin's Pithampur Unit-2 as Official Action Indicated
The US Food and Drug Administration (FDA) has concluded its inspection of Lupin’s Pithampur Unit-2 manufacturing facility, issuing a Form 483 with four observations.
Current Good Manufacturing Practice (cGMP) | 04/10/2025 | By Dineshwori
Bionova Scientific, a full-service biologics contract development and manufacturing organisation (CDMO) and subsidiary of Asahi Kasei, has inaugurated a 10,000-square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Current Good Manufacturing Practice (CGMP) | 13/08/2025 | By Darshana | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy